Sunoptic Technologies has acquired LuxteL
Sunoptic Technologies has acquired LuxteL for an undisclosed consideration.
Sunoptic Technologies® OEM Business is focused in four major market segments: medical technology, life science, industrial/machine vision, and dental for product development and manufacturing of fiberoptic and illumination applications. Sunoptics Surgical® provides surgical headlights, Xenon and LED light sources, video cameras, documentation/recording devices, fiber optic cables and other related products. The company was founded 35 years ago and is based in Jacksonville, Florida.
LuxteL's focus in the specialty lighting industry is on a family of ceramic xenon short arc lamps, trademarked CeraLux. These products are more rugged, offer better color rendition and eliminate environmental concerns associated with other lighting techniques.
Oaklins' team in Jacksonville advised the buyer in this transaction.
Talk to the deal team
Related deals
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn more